References

  1. World Health Organization. (WHO) guidelines; Rapid advice antiretroviral therapy for HIV infection in adults and adolescents. 2009. Geneva.

  2. Walensky Rochelle P, Robin Wood, Andrea L Ciaranello, A David Paltiel, Sarah B Lorenzana,et al. Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis. PLoS Med. 2010 Dec 21;7(12):e1000382.. This article on PubMed

  3. UNAIDS. AIDS Epidemic Update. 2009. Geneva: UNAIDS/WHO.

  4. UNAIDS. Report on the Global AIDS Epidemic. 2008. Geneva: Joint United Nations Program on HIV/AIDS.

  5. UNAIDS. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report. 2007.

  6. Mills E, Cooper C, Anema A, Guyatt G. Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med. 2008 Jul;9(6):332-5.. This article on PubMed

  7. Mattson CL, Campbell RT, Bailey RC, Agot K, Ndinya-Achola JO, Moses S. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One. 2008 Jun 18;3(6):e2443.. This article on PubMed

  8. United Nations General Assembly (UNGA); Uniting for universal access: towards zero new HIV infections, zero discrimination and zero AIDS-related deaths. Report of the secretary general, March 2011. New York. UN.

  9. UNAIDS. Getting to Zero. 2011-2015 strategy. 2011.

  10. Donnell, D, Baeten, J M, Kiarie, J, Katherine K Thomas MS b, Wendy Stevens et al. Heterosexual HIV-1 Transmission after Initiation of Antiretroviral Therapy: A Prospective Cohort Analysis. Lancet. 2010; 375 (9731): 2092-8. This article on PubMed

  11. Montaner, J S G, Lima, V D, Barrios, R, Yip Benita , Wood Evan , Kerr Thomas et al. Association of Highly Active Antiretroviral Therapy Coverage, Population Viral Load, and Yearly New HIV Diagnoses in British Columbia, Canada: A Population-based Study. Lancet. 2010; (376) 9740: 532-9. This article on PubMed

  12. Kenya AIDS Indicator Survey 2007(KAIS). 2008. Nairobi Kenya. National AIDS and STI Control Programme, Ministry of Health Kenya (NASCOP).

  13. World Health Organization and Charles Gilks and Marco Vitorio guidelines development group. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach - 2006 revision. Geneva. WHO.

  14. National AIDS and STI Control Program (NASCOP), Ministry of health, Kenya National Clinical Manual for ART Providers, 2nd Edition, 2007. Kenya. MOH-Kenya.

  15. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010; 15 (Suppl 1):1-15. This article on PubMed

  16. Cornell M, McIntyre J, Myer L. Men and antiretroviral therapy in Africa: our blind spot. Trop Med Int Health. 2011 Mar 21.. This article on PubMed

  17. WHO/UNAIDS/UNICEF. towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector, September 2010: http://www.who.int/hiv/pub/2010progressreport/report/en/index

  18. Lugada Eric S, Jonathan Mermin, Frank Kaharuza,EllingUlvestad,Willy Were, Nina Langeland et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol. 2004 Jan;11(1):29-34.. This article on PubMed

  19. Kassu A, Tsegaye A, Petros B, Dawit Wolday, Ermias Hailu, Tesfaye Tilahun et al. Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol. 2001 Nov;8(6):1171-6.. This article on PubMed

  20. Anzala AO, Simonsen JN, Kimani J, Ball TB, Bagelkerke NJ, Rutherford J et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia,increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis. 2000 Aug;182(2):459-66.. This article on PubMed

  21. Taylor JM, Tan SJ, Detels R, Giorgi JV. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV infected individuals. AIDS. 1991 Feb;5(2):159-67.. This article on PubMed

  22. Brian G Williams, Eline L Korenromp, Eleanor Gouws, George P Schmid, Bertran Auvert and Christopher Dye. HIV Infection, Antiretroviral Therapy, and CD4+ Cell Count Distributions in African Populations. J Infect Dis. 2006 Nov 15;194(10):1450-8.. This article on PubMed

  23. National AIDS Control Council (NASCOP). Kenya HIV prevention response and modes of transmission analysis Final Report. March 2009. Kenya National AIDS Control Council

  24. UNAIDS. Treatment 2. 0. Is this the future of treatment? 2009.

  25. Emery S, Neuhaus JA, Phillips AN et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.J Infect Dis. 2008 Apr 15;197(8):1133-44. . This article on PubMed

  26. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, et al. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009 Aug 4;151(3):157-66.. This article on PubMed

  27. Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272.. This article on PubMed

  28. Cohen, M, & Gay, C. Treatment to Prevent Transmission of HIV-1. Clinical Infectious Diseases. 2010; 50 (Suppl 3):S85-95. This article on PubMed

  29. Dodd, P J, Garnett, G, & Hallett, T B. Examining the Promise of HIV Elimination by "Test and Treat" in Hyperendemic Settings. AIDS. 2010; 24 (5): 729-35. This article on PubMed